QIAGEN N.V. Enhances Bioinformatics Portfolio With Acquisition Of OmicSoft
HILDEN, Germany and GERMANTOWN, Maryland, January 9, 2017 /PRNewswire/ --
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of OmicSoft Corporation, providing access to OmicSoft's powerful multi-omics data management infrastructure solution as well as expertly curated 'omics' data sets that complement QIAGEN's bioinformatics portfolio that are relied upon by customers worldwide to gain valuable insights into complex biological data.
OmicSoft is recognized for its suite of cutting-edge software solutions that enable scientists and researchers to efficiently analyze and visualize their own data sets and compare them to massive volumes of publicly available 'omics' data sets - such as The Cancer Genome Atlas (TCGA) operated by the U.S. National Cancer Institute - and share results with colleagues. These solutions, which integrate enterprise access and cloud-based resources, are essential in addressing the rapidly growing need of researchers in discovery and translational research to manage, compare and share the massive volumes of data on DNA, RNA and other biological variables generated with next-generation sequencing (NGS) technologies.
OmicSoft is expected to greatly enhance QIAGEN's industry-leading bioinformatics portfolio by adding key features for the management, analysis and sharing of both primary data and analyzed results, while also expanding the range of QIAGEN's translational and clinical applications.
Click here for full press release
QIAGEN contacts:
Investor Relations
John Gilardi +49-2103-29-11711
Dr. Sarah Fakih +49-2013-29-11457
e-mail: ir@QIAGEN.com
Public Relations
Dr. Thomas Theuringer +49-2103-29-11826
e-mail: pr@QIAGEN.com
SOURCE QIAGEN N.V.